However, secondary preventative interventions such as antiplatelet drugs, -blockers, angiotensin-converting-enzyme (ACE) inhibitors, angiotensin-receptor blockers (ARBs), and HMG-CoA reductase inhibitors (statins) have been shown to significantly reduce CVD risk [3]
If you need weight loss treatment now, FDA-approved options like semaglutide and tirzepatide are available today with years of real-world safety data
Manufactured without milk, eggs, fish, crustacean shellfish, peanuts, wheat and gluten
Thyroid C-cell risk has been observed in rodent studies, where GLP-1 receptor agonists led to C-cell tumor development
Comparing reconstitution approaches across GLP-1 peptides Semaglutide is not the only GLP-1 receptor agonist that researchers work with
A recent observational study looked at possible links between IGF-1 and frailty